Gelteq Limited.
GELS.US | Manufacture of medical and dental instruments and supplies
Gelteq Limited, trading on the NASDAQ under the ticker GELS, is a company focused on the development and commercialization of novel, non-invasive medical devices. Their primary product is a device designed to treat overactive bladder (OAB) in women. The company's focus is on providing a non-surgical...Show More
Better Health for All
20
Gelteq Limited's core business is entirely focused on developing and commercializing novel, non-invasive medical devices and gel-based drug/nutrient delivery systems.
1
Its primary product is a non-surgical, patient-friendly alternative for treating overactive bladder (OAB) in women.
The company's technology aims to improve patient experience, reduce choking risk, and enhance medication compliance, indicating that 100% of its product portfolio delivers exceptional health benefits.
2
There is no evidence of any products or activities with negative health outcomes or revenue derived from such.
3
The company has an expanding patent portfolio, but no information is provided regarding its approach to patent flexibility in relation to global health needs.
4
No specific data on safety records, adverse events, recalls, pricing, accessibility, vulnerable populations, R&D investment percentages, health externalities, health equity programs, healthcare workforce support, preventative health measures, healthcare data responsibility, global health crisis response, mental health initiatives, nutrition and food safety, healthcare education, addiction mitigation, or clinical trial ethics is available.
5
Fair Money & Economic Opportunity
0
No evidence available to assess Gelteq Limited on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
Gelteq Limited had a small workforce of 7 full-time and 1 part-time employee as of June 30, 2024.
1
Due to this small headcount, the company falls under the N/A threshold for living wage coverage and insecure contract share metrics. Similarly, with a limited number of employees, a meaningful CEO-to-median employee pay ratio cannot be assessed. The company reported no specific regulatory actions, violations, or fines related to labor practices in its financial filings for the past two years.
2
Fair Trade & Ethical Sourcing
0
No specific, concrete data points were found in the provided articles regarding Gelteq Limited's fair trade certifications, supplier audit frequency, forced or child labor incidents, supply chain traceability, remediation speed for violations, ethical sourcing clause coverage in contracts, materials risk index, or supplier diversity spend.
1
The articles focus on the company's mission, partnerships, and leadership, rather than its supply chain practices.
2
Honest & Fair Business
0
No specific, quantitative, or factual evidence was found in the provided articles for any of the KPIs related to Honest & Fair Business. Information regarding regulatory fines, transparency index scores, the strength of whistleblower policies, financial restatements, audit coverage, ESG controversy scores, complaint resolution times, board conflict-free percentages, anti-corruption policies, or third-party verification was not available.
1
Kind to Animals
0
No specific, concrete data points were found in the provided articles to assess Gelteq Limited against the 'Kind to Animals' value. While the company is involved in animal health products, including testing samples of canine and feline products for palatability and planning formal studies for canine products in the fiscal year ending June 30, 2026, and received FDA approval for a suitability petition for a new animal drug that did not require further safety and effectiveness studies for that specific drug, this information does not provide quantitative data or policy details relevant to any of the KPIs in the rubric.
1
No War, No Weapons
0
Gelteq Limited's core business is the development and commercialization of non-invasive medical devices. The company reported AUD$0 revenue for the fiscal year ended June 30, 2024, and AUD$79,843 for the fiscal year ended June 30, 2023, all derived from its medical device activities.
1
There is no evidence in the provided articles of any revenue from arms or defense contracts, nor any involvement in defense-related activities.
2
Planet-Friendly Business
0
No specific, concrete data points were found in the provided article for any of the Planet-Friendly Business KPIs. The article explicitly states 'Not found' for all relevant environmental metrics, including greenhouse gas emissions, renewable energy use, water consumption, waste diversion, and climate-related targets or initiatives.
1
Respect for Cultures & Communities
0
No specific data or information regarding Gelteq Limited's performance on 'Respect for Cultures & Communities' was found in the provided articles.
1
All articles indicated that no relevant data could be extracted or that the requested pages were not found.
2
Safe & Smart Tech
0
The provided articles do not contain specific, concrete data points or information relevant to any of the 'Safe & Smart Tech' KPIs. explicitly states that no data on cybersecurity, privacy, or AI-related metrics, including data breaches, security investments, or certifications, is available.
1
's content was unavailable, preventing any assessment from that source.
2
Zero Waste & Sustainable Products
0
No specific, concrete data points were found in the provided articles regarding Gelteq Limited's (GELS.US) performance on waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.
1
refers to 'The GEL Group, Inc.' and is not relevant to Gelteq Limited (GELS.US).
2